John W. Singleton, MD, FACP
Professor of Medicine, Retired
Education
- Medical School: MD, cum laude, Harvard Medical School, 1957
- Internship/Residency: Massachusetts General Hospital, Boston, MA, 1957-1962
- Fellowship: University of Colorado School of Medicine, Denver, CO, 1962-1965
Honors and Awards
- Phi Beta Kappa, 1952
- Alpha Omega Alpha, 1956
- Boylston Medical Society, 1956
- Henry Christian Prize, 1957
Faculty Appointments
- Instructor in Medicine, 7/1/63-6/30/65
- Assistant Clinical Professor of Medicine, 7/1/65-4/30/68
- Assistant Professor of Medicine, 5/1/68-7/1/72
- Associate Professor of Medicine, 7/1/72-6/30/83
- Associate Dean for Faculty Affairs, 9/1/72-6/30/76
- Professor of Medicine, 7/1/83-
- Director, Introduction to Clinical Medicine, 9/1/83-
- Associate Dean for Academic Affairs, 9/1/83-6/30/85
- Associate Dean for Faculty Affairs, 7/1/85-5/31/89
- Visiting Professor of Medicine, Shanghai Second Medical University, Shanghai, China, 1989-
- Visiting Professor of Medicine, Hunan Medical University, Changsha, Hunan, China, 1989-92
Committees and Responsibilities
- Member, Merit Review Board in Gastroenterology, Veterans Administration, 1975-78
- National Foundation for Ileitis and Colitis, Inc.
- Scientific Advisory Committee, 1975-78
- Grants Review Committee, 1981-84
- Research Training Awards Committee, 1984-
- Research Development Committee, 1984-89
- Member Operations Committee, VA Cooperative Trial of Variceal Sclerotherapy, 1983-90
- National Commission on Digestive Diseases Workgroup Leader: "Clinical Research", 1977-79
- Board Member, Visiting Nurse Association of the Denver Area, Inc., 1980-82
- Member, Board of Trustees, Kent-Denver Country Day School, 1980-86
- Member, Subspecialty Board of Gastroenterology, American
- Board of Internal Medicine, 1983-89
- Member, Editorial Board, Controlled Clinical Trials, 1983-86
Research Interests
- Inflammatory Bowel Disease
- Controlled Clinical Trials, design and administration
- Epidemiology of inflammatory bowel disease
Representative Publications
- Sands BE, Bank S, Sninsky CA, Robinson M, Kats S, Singleton JW, et al. Preliminary Evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn’s disease. Gastroenterology 1999,117:58-64. (download PDF)
- Singleton JW. The Crohn’s Disease Activity Index is a useful tool in clinical practice of gastroenterology. Inflammatory Bowel Diseases 1999, 5:138.
- Lashner BA, Singleton JW. Re: Bernstein et al: surveillance colonoscopy in ulcerative colitis [letter;comment]. Am J Gastroenterol 1996,91:1472-1473.
- Singleton JW, Hanauer S, Robinson M. Quality-of-life results of a double-blind, placebo-controlled trial of mesalamine in patients with Crohn’s disease. 1995, Digestive Dis Science 40:931-935.
